Drug Profile
DTS 201
Alternative Names: CPI 0004; CPI 0004Na; Super-Leu-DoxLatest Information Update: 12 Feb 2010
Price :
$50
*
At a glance
- Originator Medarex
- Developer Diatos
- Class Anthracyclines; Antineoplastics; Doxorubicins
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Prostate cancer
Most Recent Events
- 30 Sep 2009 Phase-II clinical trials in Breast cancer in Europe (IV)
- 30 Sep 2009 Phase-II clinical trials in Prostate cancer in Europe (IV)
- 23 Oct 2007 Data presented at the 19th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2007) added to the adverse events and Cancer therapeutic trials sections